Genetic Technologies (AU:GTG) has released an update.
Genetic Technologies Limited has announced an extension for its Entitlement Offer Prospectus until December 2, 2024, providing investors more time to consider participation. This non-renounceable pro-rata issue update aims to enhance investor engagement and potentially bolster the company’s capital base.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.
